4.8 Article

The Glycogen-Binding Domain on the AMPK β Subunit Allows the Kinase to Act as a Glycogen Sensor

Journal

CELL METABOLISM
Volume 9, Issue 1, Pages 23-34

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2008.11.008

Keywords

-

Funding

  1. Wellcome Trust
  2. EXGENESIS Integrated Project [LSHM-CT-2004-005272]
  3. Division of Signal Transduction Therapy at Dundee (AstraZeneca, Boeringer-Ingelheim, GlaxoSmithKline, Merck & Co. Inc, Merck KgaA, and Pfizer)

Ask authors/readers for more resources

AMPK beta subunits contain a conserved domain that causes association with glycogen. Although glycogen availability is known to affect AMPK regulation in vivo, the molecular mechanism for this has not been clear. We now show that AMPK is inhibited by glycogen, particularly preparations with high branching content. We synthesized a series of branched oligosaccharides and show that those with a single alpha 1 -> 6 branch are allosteric inhibitors that also inhibit phosphorylation by upstream kinases. Removal of the outer chains of glycogen using phosphorylase, thus exposing the outer branches, renders inhibition of AMPK more potent. Inhibition by all carbohydrates tested was dependent on the glycogen-binding domain being abolished by mutation of residues required for carbohydrate binding. Our results suggest the hypothesis that AMPK, as well as monitoring immediate energy availability by sensing AMP/ATP, may also be able to sense the status of cellular energy reserves in the form of glycogen.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available